Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-09

Clinical Trial Update: Uric Acid Lowering Trial in Youth Onset T2D [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating uric acid lowering in youth-onset type 2 diabetes with diabetic kidney disease and hyperuricemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Colorado, Denver | Conditions: Diabetic Kidney Disease, Hyperuricemia | Phase 2 | Status: UNKNOWN